SAM ZUCKER concentrates on corporate transactions for high growth, life sciences, healthcare and technology companies in the U.S., Asia, and throughout the world, including representations of investors and portfolio companies in biotechnology, healthcare and medical devices. His practice covers three main areas:
Business Combinations & Collaborations: Sam represents both buyers and sellers in mergers and acquisitions and divestitures. He works on joint ventures, strategic alliances and collaborations. Sam collaborates extensively with the firm’s ex-US offices on international and multi-jurisdictional transactions.
Financings: Sam works on venture capital, startup and private equity financings as well as public company securities offerings (including IPO’s, follow-ons, CMPOs, registered directs and PIPES). He also handles regulatory matters, primarily, SEC, NASDAQ and ISS matters.
Corporate Governance: Sam advises his clients’ management and board of directors on corporate governance and critical strategic matters – including acquisitions, corporate development and capital market strategies as well as general corporate, public company reporting and market regulatory issues.